BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8395744)

  • 41. Correlation between maternal serum antibodies and protection against bovine rotavirus diarrhea in calves.
    Kohara J; Tsunemitsu H
    J Vet Med Sci; 2000 Feb; 62(2):219-21. PubMed ID: 10720197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Passive protection against bovine rotavirus in calves by specific immunoglobulins from chicken egg yolk.
    Kuroki M; Ohta M; Ikemori Y; Peralta RC; Yokoyama H; Kodama Y
    Arch Virol; 1994; 138(1-2):143-8. PubMed ID: 7980004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and immunologic characterization of group A bovine rotavirus field isolates with P8[11] spike protein.
    Campbell RE; Lu W; White AK; Duhamel GE
    Arch Virol; 1998; 143(5):1021-8. PubMed ID: 9645207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Serotyping of cytopathic rotavirus strains isolated from calves].
    Georgiev GK; Kharalambiev KhE
    Vet Med Nauki; 1985; 22(8):7-12. PubMed ID: 3002007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Independent segregation of the VP4 and the VP7 genes in bovine rotaviruses as confirmed by VP4 sequence analysis of G8 and G10 bovine rotavirus strains.
    Taniguchi K; Urasawa T; Urasawa S
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1215-21. PubMed ID: 8389807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses.
    Jin Q; Ward RL; Knowlton DR; Gabbay YB; Linhares AC; Rappaport R; Woods PA; Glass RI; Gentsch JR
    Arch Virol; 1996; 141(11):2057-76. PubMed ID: 8973523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterologous protection against rotavirus-induced disease in gnotobiotic piglets.
    Bishop RF; Tzipori SR; Coulson BS; Unicomb LE; Albert MJ; Barnes GL
    J Clin Microbiol; 1986 Dec; 24(6):1023-8. PubMed ID: 3023436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of cross-reactive serum neutralizing antibody to human rotavirus in calves after in utero administration of bovine rotavirus.
    Wyatt RG; Kapikian AZ; Mebus CA
    J Clin Microbiol; 1983 Sep; 18(3):505-8. PubMed ID: 6313744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neutralizing antibody immune response in children with primary and secondary rotavirus infections.
    Arias CF; López S; Mascarenhas JD; Romero P; Cano P; Gabbay YB; de Freitas RB; Linhares AC
    Clin Diagn Lab Immunol; 1994 Jan; 1(1):89-94. PubMed ID: 7496929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A longitudinal cohort study in calves evaluated for rotavirus infections from 1 to 12 months of age by sequential serological assays.
    Cao D; Igboeli B; Yuan L; Kapikian AZ; Ayers JL; Abinanti FR; Hoshino Y
    Arch Virol; 2009; 154(5):755-63. PubMed ID: 19343476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigenic relationships between rotaviruses from different species as studied by neutralization and immunofluorescence.
    Sato K; Inaba Y; Miura Y; Tokuhisa S; Matumoto M
    Arch Virol; 1982; 73(1):45-50. PubMed ID: 6181760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of antigenicity between recently isolated bovine rotaviruses A and vaccine strains by cross-neutralizing antibody tests and their significance for immunization.
    Hasan MA; Kabir MH; Miyaoka Y; Yamaguchi M; Shoham D; Takehara K
    J Vet Med Sci; 2023 Mar; 85(3):318-325. PubMed ID: 36596544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New P serotype of group A human rotavirus closely related to that of a porcine rotavirus.
    Okada Ji; Urasawa T; Kobayashi N; Taniguchi K; Hasegawa A; Mise K; Urasawa S
    J Med Virol; 2000 Jan; 60(1):63-9. PubMed ID: 10568765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The lesions of rotavirus infection in 1- and 10-day-old gnotobiotic calves.
    Varshney KC; Bridger JC; Parsons KR; Cook R; Teucher J; Hall GA
    Vet Pathol; 1995 Nov; 32(6):619-27. PubMed ID: 8592796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic and serological characterization of novel serotype G8 bovine group A rotavirus strains isolated in Japan.
    Fukai K; Onoda H; Itou T; Sato M; Miura Y; Sakai T
    J Vet Med Sci; 2004 Nov; 66(11):1413-6. PubMed ID: 15585957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterisation of G serotype dependent non-antibody inhibitors of rotavirus in normal mouse serum.
    Beisner B; Kool D; Marich A; Holmes IH
    Arch Virol; 1998; 143(7):1277-94. PubMed ID: 9722874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization.
    Hoshino Y; Wyatt RG; Greenberg HB; Flores J; Kapikian AZ
    J Infect Dis; 1984 May; 149(5):694-702. PubMed ID: 6202807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.
    Hoshino Y; Sereno MM; Midthun K; Flores J; Kapikian AZ; Chanock RM
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8701-4. PubMed ID: 3001716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection and differentiation of bovine group A rotavirus serotypes using polymerase chain reaction-generated probes to the VP7 gene.
    Parwani AV; Rosen BI; Flores J; McCrae MA; Gorziglia M; Saif LJ
    J Vet Diagn Invest; 1992 Apr; 4(2):148-58. PubMed ID: 1319748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.
    Kobayashi N; Taniguchi K; Urasawa T; Urasawa S
    Arch Virol; 1991; 121(1-4):153-62. PubMed ID: 1722090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.